Abstract Body

Background:

Poxviruses have developed strategies to evade host antiviral immunity, particularly the Interferon (IFN) response, but limited data are available for Monkeypox virus (MPXV). To better understand how MPXV affects the IFN response, we analyzed type I, II and III IFNs and IFN stimulated genes (ISGs) expression in different MPXV-infected anatomical sites from male patients. Also, we investigate MPXV in vitro sensitivity to different type of IFNs.

Methods:

Eighteen samples from different anatomical sites [Skin lesions (SL), anal canal brushing (ACB) and nasopharyngeal swabs (NSP)] were collected from MPXV-infected male patients. Gene expression of type I (IFN-α/β/ω), type II (IFN-γ), type III IFNs (IFN-λ1/2/3) and ISGs (ISG15, ISG56 and PKR) was measured by quantitative RT-PCR assays. MPXV-DNA levels were evaluated by Bioperfectus Monkeypox Virus Real Time PCR kit. Antiviral assays were performed to evaluate MPXV (MOI=0.1) sensitivity to different types of IFNs (IFN-α, IFN-α natural, IFN‐β, IFN-ω and IFN-γ) on different cell lines (human lung adenocarcinoma epithelial A549 cells, cervival carcinoma HeLa cells and african green monkey kidney VeroE6 cells). Viral yield after IFN treatment was quantified in VeroE6 cells.

Results:

Examination of IFN-related genes across anatomical sites revealed that IFN-α, IFN-λ1, and PKR were significantly upregulated in ACB compared to other clinical samples. Conversely, levels of IFN-β and IFN-ω increased in SL (p<0.05). IFN-I/III and ISGs showed higher expression in samples with low MPXV-DNA Ct values, while the opposite trend was observed for IFN-γ production (p<0.05 for all the genes). Pre-treatment of A549, HeLa, and VeroE6 cells with high concentrations of IFN-α, IFN-αn, and IFN-ω (greater than or equal to 300,000 IU/mL) did not significantly inhibit MPXV replication, while MPXV exhibited moderate sensitivity to the antiviral action of IFN-β. In contrast, IFN-γ strongly inhibited MPXV replication in all the cell lines used.

Conclusions:

This study provides evidence that MPXV infection triggers the production of various types of IFNs and ISGs, with IFN-γ being particularly effective in inhibiting MPXV replication in vitro. These findings contribute to a better understanding of how MPXV evades the host immune response and may inform potential therapeutic strategies for MPXV infections.